At PBD, we partner to develop Actiphage for the acceleration of latent tuberculosis (LTBI) test and treat campaigns and TB drug research through the following:
- Laboratory-developed tests to support research studies for latent tuberculosis screening.
- Companion diagnostic TB drug research partnerships for preventive TB therapy and drug management.
- Co-development of Actiphage on qPCR diagnostic platforms and downstream commercial partnerships.
- Automated technology partnerships to support Actiphage’s sample collection and laboratory preparation.
Our leadership team is ready to meet with you to share our capabilities and discuss your business needs. We are always looking for innovation and new partnership opportunities that align with our focus on TB diagnosis.
For more information please contact Jonnie Yewdall, Chief Commercial Officer at Jonnie.Yewdall(@)pbdbio.com
